))
Darryl Hudson is Developing Psilocybin-Based Therapeutics
Manage episode 382855065 series 3342868
Content provided by PsychedelicInvest.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PsychedelicInvest.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Darryl Hudson, the Co-Founder and CIO of GoodCap Pharmaceuticals.
Darryl Hudson is a PhD in Molecular Biology and Genetics and is active in the Hemp, Cannabis and Psychedelic Drug Development Industries.
GoodCap Pharmaceuticals Inc. (goodcap.com) is a leading Canadian drug development company devoted to harnessing and applying the physical and mental health benefits of mushrooms and mushroom-derived compounds. GoodCap is a leader in formulation, research and development of psilocybin-based therapeutic products and is dedicated to discovering natural therapies for inflammatory disorders and mental health conditions.
50 episodes
Share
